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This investigation was initiated to study the
kinetics of C19 and C18 steroids in maternal plasma
following application of 3H-labelled estrogen·
precursors to the fetal compartment. It was hoped
to obtain Information about the quantity and
quality of the fetoplacental steroid-metabolism in
the direction of fetus to mother.
In the past years LAU RITZEN and coworkers [5,6,
7] have developed a placental function test in
which dehydroepiandrosterone-sulfate s an estro-
gen-precursor was injected into the mother. There-
after the increase of the estrogen-excretion in the
24-h-urine or the estrogen level in maternal plasma
was determined s a parameter of placental meta-
bolic activity [20]. Both urinary and plasma es-
trogens rose markedly after application of the
androgenic steroidprecursor s confirmed by
investigators[2, 21,19].
The DHEA-S induced increase in urinary or plasma
estrogens provides Information about the reserve-
capacity of the placenta. Using incubation studies
with placental tissue we could demonstrate in
vitro that the conversion of DHEA to estrogens by
the placental aromatising enzyme-system is signif-
icantly reduced in pathological pregnancies (pre-
eclampsia, diabetes, postmaturity) s compared to
normal pregnancies [10, 12, 13]. These studies
demonstrated that in complicated pregnancies the
diminished capacity of the aromatizing enzyme-
system can occur and may result in a reduced
estrogen production which is of great clinical
importance. Untilnowthe dehydroepiandrosterone-
test was performed by precursor application to the
maternal compartment i.e. by intravenous injection
of DHEA-S into the maternal cubital vein. Since
the amniotic fluid has become more easily acces-
sible due to better techniques the possibility of a
new placenta function test using intraamniotic
DHEA-S injection was examined simultaneously.
In the following investigations of 4 normal preg-
nancies between the 18th to 20th week of ges-
tation, we applied (3H)-labelled dehydroepi-
androsterone-sulfate directly into the fetal com-
partment i.e. intraamniotical. Subsequently these
pregnancies were legally terminated by injection of
prostaglandine after the test-procedure.
l Materials and methods
After locating the placenta by ultrasonic Vision in
4 patients, ΙΟΟμΟί DHEA-7a-3H-sulfate (spez.
activity 1000 mCi/mmol) + 5 mg DHEA in sterile
0.9% NaCl were injected transabdominally into
the amniotic cavity. Ten milliliters of blood was
drawn from the cubital vein of the pregnant
women before injection and after 15, 30, 60,120,
180 und 240 niinutes into heparinized tubes. After
centrifugation 5 ml of plasma was incubated with
5000 IU 0-glucuronidase sulfatase (BOEHRINGER)
for 2 hrs. at pH 5.4 and 37°C in a shaking thermo-
stat. Extraction of the total free metabolites was
processed three times with ether/chloroform.
* With support of DFG SFB 87, project C5.
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The extracts were evaporated to dryness and the
dry residues were redissolved in warm methanol
and pipetted into formamid-saturated paper for
chromatography. Separation of C18 and C19-
steroids was performed in formamid/monochlor-
benzene.
The C18-steroids were rechromatographed in
formamid/chloroform, the C19-steroids in propyl-
englycol/cyclohexan (see KNÜPFEN [4] for further
details). The resulting metabolites estrone (Oej),
16a-hydroxyestrone (loa-OH-Oej) and estradiol-
(OE2-17/3) äs well äs the androgens, 4-
androstenedione and testosterone were reduced or
oxidized, rechromatographed and characterized in
the following manner:
*!. Oxidation by 3, 17/J-hydroxysteroid-reductase
(EC 1.1.1.51) type I Sigma Chemicals, St. Louis,
USA.
2. Reduction by sodiumboranate in methanol.
Estriol (Oe3), DHEA and 16a-OH-DHEA were
partially acetylated and identified by recrystal-
lization to constant specific activity.
After localization of the metabolites by parallel-
running, labelled test-chromatogramms, extraction
from the paper was performed with methanol and
radioactivity measured in a liquid-szintillation-
counter. The quantity of plasma-steroids was ex-
pressed in nCi/100 ml plasma.
2 Results
The course of the plasma-levels for each steroid-
fraction during the test-period is shown in Tab. L
The values for the 4 isolated C18-steroids over the
test-period are additionally demonstrated in graphs
(see figures). From the C18-steroids, the two C16
hydroxylated compounds, estriol and 16-hydroxy-
estrone, have been isolated. Seventy-five percent
of all originating estrogens were hydroxylated at
C16. Estradiol-17/3 and estrone were found in
approximately the same quantity. In contrast the
estriol level was 2 to 3 times higher than that of
the other estrogens. The peak plasma concentration
of all C18-steroids appeared 180 minutes after
(3H)-DHEA-S injection with the exception of
estrone which reached its maximum concentration
slightly earlier, that is after 120 minutes.
From the C19-steroid-fr?ction, 16a-hydroxy-
DHEA was isolated with highest concentration in
plasma. The recovery of unchanged (3H)-DHEA-S,
the steroid that had been initially injected, was
somewhat lower.
The plasma-levels of A4-androstenedione and
testosterone were almost equal. The plasma-levels
of the C19-steroids showed the same temporal
course äs those of the C18-steroids. The highest
values were detected at 180 minutes.
3 Discussion
The fetal adrenal cortex produces 75% of the total
DHEA-S which is then primarily C-l 6-hydroxylated
in the fetal liver. DHEA-S and 16a-OH-DHEA-S
reach the placenta äs estrogen-precursors through
the umbilical arteries and are converted via
androstenedione and 19-hydroxyandrostenedione
to estrogens, mainly to estriol [l, 14,17,18]. For
this conversion the placenta is provided with the
following enzymes arylsulfatase, 3j3-hydroxy-
steroiddehydrogenase-A4-As-isomerase, 19-hy-
droxylase and the aromatizing enzymesystem. The
additional activity of the placental microsomal
enzyme 170-hydroxysteroiddehydrogenase causes
formation of testosterone by reduction of andro-
stenedione and also of estradiol-17/3 from estrone
[16, 8]. In our injection study we simulated physi-
ological processes described above by applying the
labelled and unlabelled DHEA directly to the feto-
placental unit by intraamniotical injection.
The quantity of the exogenous hormones admin-
istered in our test is within the normal physiological
ränge. The normal fetus produces about 70 mg
DHEA-S in 24 hrs.; however, we injected 5 mg
unlabelled DHEA and measured its metabolites
over a 4 hr. period. Only 5 g of labelled DHEA
was used to enable qualitative analysis.
Previous investigators have shown that prior to the
20th week of gestation the fetus sw.allows signif-
icant volumes of amniotic fluid. The high 16 -
hydroxylaseactivity of the fetal liver [9, 11] causes
C16-hydroxylation of 75% of all recovered met-
abolites (Tab. I): The main 16-hydroxylated met-
abolite is 16a-OH-DHEA and after placenta-
passage 16a-OH-estrone and estriol. 15 minutes
after intraamniotic injection of DHEA-S a signif-
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icant quantity of labelled metabolites appears in
the maternal circulation. As illustrated in the
graphs, the plasmalevels of the metabolites in all 4
cases tested increased up to 3 hrs. after injection
and then decreased rather quickly. Our Inter-
pretation of the results is, that the fetus continously
swallows the amniotic fluid (approx. 300—500 ml
in the 20 th week fo gestation) containing the
dispersed radioactive steroid, metabolizes it and
delivers it into the maternal circulation after
placental passage. This consecutive release of steroid
hormones by the placenta might explain the
relatively high levels in maternal plasma over
several hours, since the elimination of steroids by
the kidney is rapid i.e. within 30 minutes. Twenty
five percent of the swallowed DHEA is not C16-
hydroxylated and therefore seems not to pass the
fetal liver and consequently to reach the placenta
without 16a-hydroxylation. Here it is converted
to A4-androstenedionetestosterone and to estrone
and estradiol-17/3 via the A4-metabolic pathway.
These fractions enter the maternal circulation and
were identified in plasma äs shown in table I. One
could assume that a small part of the intraamnioti-
cally injected DHEA could be reabsorbed by the
amnion and reaches the maternal circulation
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Fig. 1-4. Levels of the four main C18-steroids in maternal plasma of 4 patients following intraamniotic injection of
ΙΟΟμ/Ci DHEA-7a-3H-sulfate in midpregnancy.
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directly in this manner without 16a-hydroxylation.
This assumption is supported by the recovery of
small amounts of unmetabolized labelled DHEA.
HAUSKNECHT and MANDELMAN [3] have found
an increase of estriol in 24-hr-urine samples after
intraamniotic application of unlabelled DHEA.
Other metabolites were not isolated. Similar
investigations were carried out by MICH JE [15] in
pregnancies with anencephalic fetuses. In these
cases the estriol excretion in 24-hr-urine was
significantly lower than in normal pregnancies.
Our study shows that the application of labelled
estrogen-precursors to the fetal compartment and
the following recovery of C19- and CJ8-steroids in
maternal plasma give valuable Information about
thequantity of the fetoplacental steroid-metabolism
in midpregnancy.
Summary
In 4 patients with normal pregnancies between the 18th
and 20 th weck of gcstation (3H7a)-dehydroepiandro-
sterone-sulfate (|3H]-DHEA-S) was injected intraamnioti-
cally. Maternal vcnous blood was drawn before and at
rcgulai intcrvals for 240 minutes after DHEA-injection.
Thereafter, legal abortion was performed by intra-
amniotic instilJation of prostaglandine. The conjugated
steroids were hydrolyzed enzymatically and the total
steroids were isolated and identified.
The following labelled metabolites were determincd
quantitativeley:
Estriol (E3), estradiol-170 (E2-170), estrone (E^, 16 -
hydioxy-estrone, (löa-OH-Ej), dehydroepiandrosterone
(16a-OH-DHEA), A4-androstenedione (AD) and testo-
sterone (T).
The maximal increase of all estrogen fractions in maternal
plasma occuried 120-180min after intraamniotic injection
of the precursor. The most prominent rise of the C18-
steroids could be shown for estriol. 60-70% of all meta-
bolites were C16-hydroxylated.
Keywords: Feto-maternal steroid metabolism, intraamniotic injection of dehydroepiandrosterone.
Zusammenfassung
Östrogenspiegel im mütterlichen Plasma nach intraamnialer
Injektion von 3H-Dehydroepiandrosteron-Sulfat in der
Mitte der Schwangerschaft.
(3H)-Dehydroepiandrosteron-Sulfat (DHEA^S) wurde bei
vier normalen schwangeren Frauen in der 18.-20. Ge-
stationswoche direkt intraamnial verabreicht. Die Schwan-
gerschaften wurden später legal durch Prostaglandin-
Instillation unterbrochen. 15 bis 240 min nach der In-
jektion wurde Blut aus der mütterlichen Kubitalvene ent-
nommen. Im Plasma erfolgte die enzymatische Hydrolyse,
die gesamten Steroide wurden isoliert und identifiziert.
Folgende radioaktive Metabolite wurden schließlich
quantitativ gemessen: Östriol (Oe3), Östradiol-17|3
(Oe2-170), Östron (Oe^, 16a-OH-Östron, DHEA, 16 -
OH-DHea, A4-Androstendion und Testosteron. Der
maximale Anstieg aller Östrogene erfolgte im Plasma
120-180 min nach Injektion des Vorläufers. Die Östriol-
fraktion überwog bei weitem die der anderen C18-Steroide.
60-70% der Metabolite insgesamt sind an C16 hydroxy-
liert. Abschließend kann auf Grund unserer Ergebnisse
festgestellt werden, daß durch intraamniale Verabfolgung
markierter Östrogenvorläufer und durch die Wiederfin-
dung der C19- und Cjg-Steroide im Plasma der Mutter
eine gute Auskunft über die Quantität und Qualität des
fetoplacentaren Steroidstoffwechsels erhalten werden
kann.
Schlüsselwörter: Foeto-materneller Steroidstoffwechsel, intraamniale Injektion von Dehydroepiandrosteron.
Resume
Les oestrogenes dans le plasma maternel resultant d'une
injection intraamniotique de (3H)-deshydroepiandro-
steronesulfate en milieu de grossesse
Une injection intraamniotique, c.a.cL par le cöte foetal, de
(3H7a)-deshydro6piandrosteerone-sulfate ([3HJ-DHE A-S)
a ete faite chez 4 parturientes a la grossesse normale entre
la l Seme et 20eme sernaine de gestation. Les grossesses
ont ete interrompues legalement par la suite par instillation
intraamniotique de prostaglandine. Du sang a ete preleve
dans la veine cubitale de la mere a intervalles reguliers
avant et jusqu'a 240 min apres Finjection. L'hydrolyse
enzymatique s'ensuivit dans le plasma, tous les steroides
furent isoles et identifies. Enfin on a mesure quantitativ-
ement les metabolites radioactifs:
oestriol (E3), oestradiol-17/3 (E2-17/3), oestrone (Ei),
16a-hydroxy-oestrone, (löa-OH-Ej), deshydroepiandro-
sterone (DHEA), 16a-hydroxy-d6shydroepiandrosterone,
16a-OH-DHEA), A4-androstenedione (AD) et testosterone
(T).
L'augmentation maximale de tous les oestrogenes survint
dans le plasma 120-180 min apres l'injection du pre-
curseur. La fraction d Oestriol depassa de beaucoup la
J. Perinat. Med. 4 (1976) 18
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hausse des äutres steroides Cig, 60-70% de tous les
motabolites sont fiydroxyles a C^- E« conclusion on peut
constater ä la sraite de rios resultats qu'fl est possible
d'obtenir de bonnes indicaetions sur ia quantite et la qualite
du metaboiisme steroide foeto-placentaire en administrant
des precurseurs oestrogeniques marques de faQon physio-
logique par le cote foetal et en retrouvant les steroi'des
C}9 et Cjg dans le plasma de la mere.
Mots-cl&; Injection intraamniotique de deshydroopiandrosterone, metaboiisme steroide foeto-maternel
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